Last week, I had the distinct honor of getting a tour of Wilmot Cancer Center here in Rochester,NY.
The Cancer Center was designed by Donald Blair & Partners Architects and SWBR Architects to provide patients with a healing environment surrounded by natural light, beautiful artwork and compassionate caregivers.
This center is quite unique. A patient receives all of their care in one building. It is designed with the patient in mind, and makes their experience as easy and comfortable as possible.
An expanded, multi-media patient and family resource center provides education and support services along with a meditation area for quiet reflection.
My most memorable part of the tour, by far, was the research laboratory. The team of doctors and students at Wilmot have been recognized for clinical and scientific research contributions that have shaped treatments and cures.They are dedicated to achieving national leadership in cancer care and research. I was honored to be able to catch a glimpse of the teams at work-exciting to say the least!
The development of a vaccine to prevent cervical cancer began at Wilmot. Their scientists found the critical component of the vaccine designed to prevent infection with the human papilloma virus, the leading cause of cervical cancer. This vaccine is now available world-wide and could save hundreds of thousands of lives every year.
Wilmot received one of just four prestigious National Cancer Institute Specialized Program of Research Excellence grants for lymphoma research. The scientists there are collaborating with colleagues across the country to develop new therapies and tactics for deconstructing these diseases.
The future for the Wilmot Cancer Center is bright and they are proud to partner with their community and supporters- including The American Cancer Society, to continue the path of excellence that has been laid.
Wilmot's motto, “The Cure Starts Here,” is not a slogan, it’s a promise !
A special thank you to Kimberly Cenzi, Associate Director for Events and Community Outreach.
No comments:
Post a Comment